HALOZYME THERAPEUTICS, INC. - COM (HALO)

Historical Portfolio Holders from Q1 2014 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
120 M
Holdings value Q1 2024
$4.86 B
Value change Q1 2024
-$56.3 M
Grand Portfolio weight change Q1 2024
0%
Number of holders
396
Number of buys Q1 2024
202
Number of sells Q1 2024
-190
Average buys Q1 2024 %
+0.002%
Average sells Q1 2024 %
-0.001%
CUSIP
40637H109
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 120 M $4.86 B -$56.3 M $40.68 396
2023 Q4 122 M $4.53 B +$75.3 M $36.96 405
2023 Q3 121 M $4.63 B +$384 K $38.20 386
2023 Q2 121 M $4.35 B -$98.1 M $36.07 363
2023 Q1 123 M $4.68 B -$296 M $38.19 377
2022 Q4 128 M $7.3 B -$109 M $56.90 411
2022 Q3 122 M $4.81 B +$122 M $39.54 336
2022 Q2 125 M $5.51 B +$52.9 M $44.00 348
2022 Q1 126 M $5.03 B -$48.4 M $39.88 293
2021 Q4 127 M $5.09 B -$91.5 M $40.21 308
2021 Q3 127 M $5.16 B +$15.5 M $40.68 313
2021 Q2 127 M $5.78 B -$73.4 M $45.41 305
2021 Q1 130 M $5.44 B -$157 M $41.69 327
2020 Q4 135 M $5.76 B +$136 M $42.71 329
2020 Q3 132 M $3.48 B -$48.4 M $26.28 259
2020 Q2 133 M $3.57 B +$197 M $26.81 251
2020 Q1 129 M $2.31 B +$49.4 M $17.99 199
2019 Q4 127 M $2.25 B +$8.21 M $17.73 215
2019 Q3 124 M $1.92 B +$57.7 M $15.51 200
2019 Q2 122 M $2.1 B +$235 M $17.18 196
2019 Q1 118 M $1.91 B -$285 K $16.10 192
2018 Q4 118 M $1.72 B -$44.2 M $14.63 180
2018 Q3 123 M $2.23 B +$6.55 M $18.17 188
2018 Q2 123 M $2.07 B -$3.33 M $16.87 190
2018 Q1 124 M $2.42 B +$15.5 M $19.59 207
2017 Q4 122 M $2.48 B +$23.9 M $20.26 197
2017 Q3 121 M $2.11 B -$3.48 M $17.37 168
2017 Q2 121 M $1.56 B +$86.2 M $12.82 165
2017 Q1 115 M $1.49 B +$199 M $12.96 154
2016 Q4 111 M $1.09 B +$44.5 M $9.88 170
2016 Q3 106 M $1.28 B +$17.3 M $12.08 163
2016 Q2 105 M $906 M +$19.5 M $8.63 163
2016 Q1 100 M $949 M +$16.5 M $9.47 159
2015 Q4 98.8 M $1.71 B +$8.21 M $17.33 165
2015 Q3 98.1 M $1.32 B +$3.59 M $13.43 175
2015 Q2 94.7 M $2.14 B +$79.2 M $22.58 157
2015 Q1 92.1 M $1.32 B +$56.8 M $14.28 136
2014 Q4 91.2 M $880 M +$20.2 M $9.65 132
2014 Q3 89 M $810 M +$28.6 M $9.10 119
2014 Q2 85.7 M $846 M -$18.7 M $9.88 129
2014 Q1 85.9 M $1.09 B +$76.3 M $12.70 132